Frontida BioPharm is a contract development and manufacturing organization focused on supplying oral pharmaceuticals for cardiovascular, gastrointestinal, endocrine, CNS conditions and infectious diseases. Its Duragran process technology allows creating controlled release beadlets and granules of uniform and narrow particle size range. The company also offers AdaptDose technology platform.